SPITALUL CLINIC JUDETEAN MURES

Clement What the numbers say about this buyer

• 89% of this buyer's awards went to companies that had already won here before (9,037 awards since 2021, spread over 350 companies). That is well above the national norm (76%) — newcomers have a harder time here than elsewhere.n = 9,037 awards since 2021
• The award came in at a median 69% of the estimated value (21 awards with both estimate and value) — pricing at the estimate is usually too high here. Country: 83%.n = 21
• The median procedure drew 5 bids (6,966 procedures with a bid count); 10% ended with a single bidder. Country: median 5.3 bids.n = 6,966
• 51% of the bids received came from small and medium-sized enterprises (6,579 procedures with a bid mix). Country: 68%.n = 6,579
• 5% of awards went to companies from abroad (9,037 awards with a known winner country). National average: 1%.n = 9,037
• Across 17 procedures with structured selection criteria, this buyer most often required: Trade register enrolment (17 of 17), Independent quality certificate (e.g. ISO 9001) (13 of 17), Average minimum annual turnover (12 of 17), Quality control by institutes (12 of 17).n = 17
• 2% of the bids received came from other countries (6,579 procedures with a bid mix) — all bidders, not just the winners. Country: 2%.n = 6,579

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 15/10/2026.